Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (T2DM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Handok Pharmaceuticals Co., Ltd..
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Handok Pharmaceuticals Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01805830
First received: December 26, 2012
Last updated: March 5, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)